Product Introduction:
Tglip M Tablet combines Teneligliptin 20 mg and Metformin Hydrochloride 500 mg, providing a synergistic effect to improve glycemic control by enhancing insulin secretion and decreasing hepatic glucose production.
Uses:
-
Management of type 2 diabetes mellitus
-
Used when diet, exercise, and monotherapy do not provide adequate glycemic control
-
Can be used alone or in combination with other antidiabetic drugs
Benefits:
-
Improves fasting and postprandial blood sugar levels
-
Helps reduce HbA1c levels effectively
-
Low risk of causing hypoglycemia
-
Weight-neutral effect and good gastrointestinal tolerability
Composition:
Each tablet contains:
-
Teneligliptin Hydrobromide Hydrate equivalent to Teneligliptin 20 mg
-
Metformin Hydrochloride 500 mg
Side Effects:
May cause nausea, diarrhea, abdominal discomfort, or headache. Rare cases of lactic acidosis reported; seek immediate medical attention if symptoms like muscle pain or breathing difficulty occur.
Safety Advice:
Use under medical supervision. Regular kidney function monitoring recommended. Avoid excessive alcohol consumption. Store in a cool, dry place.
